HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Mark M Fukuda Selected Research

Mark M Fukuda Research Topics

Disease

13Malaria
07/2020 - 12/2008
6Infections
09/2019 - 10/2007
5Falciparum Malaria (Plasmodium falciparum Malaria)
11/2013 - 12/2010
3Vivax Malaria
01/2020 - 01/2017
2Human Influenza (Influenza)
01/2016 - 01/2013
2Influenza in Birds (Avian Flu)
09/2009 - 10/2007
1Hemolysis
01/2020
1Retinal Hemorrhage
08/2019
1Atrophy
08/2019
1Body Weight (Weight, Body)
03/2019
1Latent Infection
11/2018
1Glucosephosphate Dehydrogenase Deficiency
10/2018
1Fever (Fevers)
01/2017
1Acute malaria
11/2013
1Parasitemia
04/2011
1Neutropenia
12/2010
1Virus Diseases (Viral Diseases)
08/2010

Drug/Important Bio-Agent (IBA)

8ArtesunateIBA
09/2019 - 12/2010
5PrimaquineFDA Link
01/2020 - 01/2017
5artemisinin (artemisinine)IBA
03/2015 - 12/2008
4Pharmaceutical PreparationsIBA
07/2020 - 12/2010
4Chloroquine (Aralen)FDA LinkGeneric
07/2020 - 08/2012
3tafenoquineIBA
08/2019 - 01/2017
3Antimalarials (Antimalarial Agents)IBA
11/2018 - 12/2010
2Glucosephosphate Dehydrogenase (Glucose 6 Phosphate Dehydrogenase)IBA
01/2020 - 10/2018
2piperaquineIBA
10/2018 - 06/2012
2artenimol (dihydroartemisinin)IBA
10/2018 - 06/2012
2RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA
01/2016 - 04/2011
2VaccinesIBA
01/2016 - 01/2013
1Exonucleases (3' 5' Exonuclease)IBA
07/2020
1plasmepsin (plasmepsin I)IBA
07/2020
1Genetic Markers (Genetic Marker)IBA
07/2020
1Retinaldehyde (Retinal)IBA
08/2019
1Matrix Metalloproteinases (MMPs)IBA
10/2018
1Antiviral Agents (Antivirals)IBA
01/2016
1Merozoite Surface Protein 1 (MSA1)IBA
11/2013
1Influenza Vaccines (Influenza Vaccine)FDA Link
01/2013
1Pyrimethamine (Daraprim)FDA Link
08/2012
1Folic Acid AntagonistsIBA
08/2012
1Quinine (Quinson)FDA Link
12/2010
1Tetracycline (Achromycin)FDA LinkGeneric
12/2010
1Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
08/2010
1Tretinoin (Retinoic Acid)FDA LinkGeneric
08/2010
1AntibodiesIBA
09/2009
1LigandsIBA
10/2007
1CytokinesIBA
10/2007

Therapy/Procedure

1AP protocol 1
09/2019
1Aftercare (After-Treatment)
04/2011
1Therapeutics
12/2010